TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients

Gijs G. Zom, Marij J. P. Welters, Nikki M. Loof, Renske Goedemans, Sinead Lougheed, Rob R. P. M. Valentijn, Maarten L. Zandvliet, Nico J. Meeuwenoord, Cornelis J. M. Melief, Tanja D. de Gruijl, Gijsbert A. Van der Marel, Dmitri V. Filippov, Ferry Ossendorp, Sjoerd H. Van der Burg

Research output: Contribution to journalArticleAcademicpeer-review

41 Citations (Scopus)
Original languageEnglish
Pages (from-to)67087-67100
JournalOncotarget
Volume7
Issue number41
DOIs
Publication statusPublished - 11 Oct 2016

Keywords

  • Toll-like receptor ligand
  • cancer vaccine
  • cervical cancer
  • conjugate
  • synthetic long peptide

Cite this